Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure?
BACKGROUND
Adhesions can result in serious clinical complications and make ileostomy closure, which is relatively simple procedure into a complicated and prolonged one. The use of sodium hyaluronate and carboxymethyl cellulose membrane (Seprafilm) was proven to significantly reduce the postoperative adhesions at the site of application. The aim of this study was to assess the incidence and severity of adhesions around a loop ileostomy and to analyze the length of time and morbidity for mobilization at the time of ileostomy closure with and without the use of Seprafilm.


METHODS
Twenty-nine surgeons from 15 institutions participated in this multicenter prospective randomized study. 191 patients with loop ileostomy construction were randomly assigned to either receive Seprafilm under the midline incision and around the stoma (Group I), only under the midline incision (Group II), or not to receive Seprafilm (Group III). At ileostomy closure, adhesions were quantified and graded; operative morbidity was also measured.


RESULTS
All 3 groups were comparable relative to gender, mean age and number of patients with prior operations (26, 25 and 19, respectively). Group II patients were significantly more likely to have pre-existing adhesions than Group III patients (30.6% vs. 14.1%, p = 0.025). At stoma mobilization, significantly more patients in Group III than in Group I had adhesions around the stoma (95.2% vs. 82.3%, p = 0.021). Mean operative times were 27, 25, and 28 minutes, respectively (p = 0.38), with significant differences among sites. There was no significant difference in the number of patients needing myotomy or enterotomy (29, 27 and 24 patients, respectively), nor in the number of postoperative complications (7, 9 and 7 patients, respectively).


CONCLUSIONS
When consistently applied, Seprafilm significantly decreased adhesion formation around the stoma but not operative times without any increase in the need for myotomy or enterotomy. These findings were not seen in the overall study population possibly due to the large number of surgeons using a variety of application techniques.
Salum
M
M
Cleveland Clinic Florida, Weston, FL 33331, USA.
Wexner
S D
SD
Nogueras
J J
JJ
Weiss
E
E
Koruda
M
M
Behrens
K
K
Cohen
S
S
Binderow
S
S
Cohen
J
J
Thorson
A
A
Ternent
C
C
Christenson
M
M
Blatchford
G
G
Pricolo
V
V
Whitehead
M
M
Doveney
K
K
Reilly
J
J
Glennon
E
E
Larach
S
S
Williamson
P
P
Gallagher
J
J
Ferrara
A
A
Harford
F
F
Fry
R
R
Eisenstat
T
T
Notaro
J
J
Chinn
B
B
Yee
L
L
Stamos
M
M
Cole
P
P
Dunn
G
G
Singh
A
A
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000714:Anastomosis, Surgical; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D007081:Ileostomy; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D011446:Prospective Studies; D013997:Time Factors; D000267:Tissue Adhesions / Q000517:prevention & control
D000276:Adjuvants, Immunologic; D008567:Membranes, Artificial; C118198:Seprafilm; D006820:Hyaluronic Acid